Preliminary results of a nearly completed phase 1-2 trial using trimodality therapy in patients with post prostatectomy high-risk pathologic (P) T2-3N0M0 prostate cancer

Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2015
This article has no abstract
Epistemonikos ID: ffdfee522bfa6d1cd49ba569fdb8c243899586d9
First added on: Feb 07, 2025